WASHINGTON, D.C. – Employers’ Prescription for Affordable Drugs (EmployersRx) issued this statement in conjunction with the ongoing debate of the Lower Drug Costs Now Act of 2019 (H.R. 3), the Prescription Drug Pricing Reduction Act (S. 2543), the Lower Health Care Costs Act (S. 1895), and other legislation proposed by both parties in the U.S.
A trio of employer groups has formed a new partnership to advocate for policies that address the problem of high—and growing—drug costs. Read about EmployersRx from The Center for Biosimilars >
When it comes to lowering skyrocketing drug prices, employers are making their voices heard on drug price transparency, drug price increase caps, and other price reducing strategies through the new coalition Employers' Prescription for Affordable Drugs (EmployersRx). Read about EmployersRx on HealthPayerIntelligence >
Employers’ Prescription for Affordable Drugs uniting to advance competition, transparency and value WASHINGTON, D.C., October 09, 2019 – The Pacific Business Group on Health (PBGH), The ERISA Industry Committee (ERIC) and the National Alliance of Healthcare Purchaser Coalitions (National Alliance) have partnered to launch the Employers’ Prescription for Affordable Drugs (EmployersRx), a coalition uniting employers